{"id":"NCT04171531","sponsor":"NICHD Pelvic Floor Disorders Network","briefTitle":"Sling vs Botox for Mixed Incontinence","officialTitle":"Treatment for Mixed Urinary Incontinence: Mid-urethral Sling vs. Botox A","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-06-08","primaryCompletion":"2024-02-12","completion":"2024-02-12","firstPosted":"2019-11-21","resultsPosted":"2025-03-20","lastUpdate":"2025-06-03"},"enrollment":150,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Urinary Incontinence, Stress","Urinary Incontinence, Urge"],"interventions":[{"type":"DRUG","name":"Botox® injection","otherNames":[]},{"type":"DEVICE","name":"Mid-urethral sling","otherNames":[]}],"arms":[{"label":"Botox A® injection","type":"ACTIVE_COMPARATOR"},{"label":"Mid-urethral sling","type":"ACTIVE_COMPARATOR"}],"summary":"The primary aim is to compare the effectiveness of intradetrusor injection of 100 unit injection of Botulinum toxin A to mid-urethral sling for change in MUI symptoms 6 months following treatment.","primaryOutcome":{"measure":"UDI-LF Total Score Change From Baseline","timeFrame":"3, 6, 9, and 12 Months","effectByArm":[{"arm":"Botox A","deltaMin":-82.2,"sd":null},{"arm":"Mid-Urethral Sling","deltaMin":-84.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"21 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":8,"countries":["United States"]},"refs":{"pmids":["40323617","38212101","34242627"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":71},"commonTop":["Urinary tract infection","Urinary retention","Coronavirus infection","Sinusitis","Residual urine volume"]}}